Investors

Insider Transactions

Date Name Sorted Ascending Title Type Shares Traded Price Range
Jan 27, 2010 kolinski stuart Officer Option Execute 4,359 8.50
Jan 27, 2010 kolinski stuart Officer Automatic Sell 4,359 27.00
Sep 19, 2008 kolinski stuart Officer Option Execute 9,992 8.50
Sep 19, 2008 kolinski stuart Officer Sell 9,992 23.40 - 23.69
Sep 9, 2013 landry robert e Officer Acquisition (Non Open Market) 5,000 n/a
Sep 1, 2011 larosa joseph j Officer Acquisition (Non Open Market) 10,000 n/a
Feb 27, 2015 mccorkle douglas s Officer Sell 3,000 416.24
Dec 17, 2014 mccorkle douglas s Officer Option Execute 2,800 30.63
Dec 16, 2014 mccorkle douglas s Officer Option Execute 6,818 30.63 - 52.03
Dec 16, 2014 mccorkle douglas s Officer Automatic Sell 5,875 410.00
Dec 16, 2014 mccorkle douglas s Officer Sell 943 410.00
Dec 15, 2014 mccorkle douglas s Officer Option Execute 1,668 30.63
Dec 15, 2014 mccorkle douglas s Officer Automatic Sell 1,668 410.16 - 417.34
Aug 27, 2014 mccorkle douglas s Officer Option Execute 1,681 21.25 - 30.63
Aug 18, 2014 mccorkle douglas s Officer Option Execute 5,875 52.03
Aug 18, 2014 mccorkle douglas s Officer Automatic Sell 5,875 353.00
Feb 20, 2014 mccorkle douglas s Officer Option Execute 3,000 21.25
Feb 11, 2014 mccorkle douglas s Officer Option Execute 5,819 30.63
Feb 11, 2014 mccorkle douglas s Officer Automatic Sell 5,819 325.00
Jan 14, 2014 mccorkle douglas s Officer Automatic Sell 4,000 290.00
Showing 341-360 of 920 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.



Close
Form content here please :)